MediSapiens

About:

MediSapiens is a software company developing online applications for biopharmaceutical researchers.

Website: http://www.medisapiens.com/

Twitter/X: medisapiens

Top Investors: Verdane, Lifeline Ventures, Finnvera Venture Capital, VTT Ventures, Eqvitec

Description:

MediSapiens is the world’s first software company for personalized cancer medicine in oncology clinics and new drug development. Company’s bioinformatics science and peer-reviewed data is based on the research since 2005 by VTT, Technical Research Centre of Finland and its collaborators. Company's online genomics data enables scientists to understand the role of human genes in health and disease – helping oncologists in choosing optimal treatments and biopharmaceutical companies in developing next generation personalized medicines.

Total Funding Amount:

$1M

Headquarters Location:

Helsinki, Southern Finland, Finland

Founded Date:

2009-01-01

Contact Email:

contact(AT)medisapiens.fi

Founders:

Sami Kilpinen

Number of Employees:

11-50

Last Funding Date:

2011-03-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai